Cours Leviathan Cannabis Group Inc Canadian Securities Exchange
Actions
CA61762Y1051
Produits pharmaceutiques
CA 2022 | 842 k 615 k 575 k | CA 2023 | 35,34 M 25,8 M 24,1 M | Capitalisation | 219 M 160 M 149 M |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -2,92 M -2,73 M | Résultat net 2023 | - 0 0 | VE / CA 2022 | 150 x |
Dette nette 2022 | 8,9 M 6,5 M 6,07 M | Dette nette 2023 | 3,32 M 2,42 M 2,26 M | VE / CA 2023 | 6,28 x |
PER 2022 |
-23,4
x | PER 2023 |
-238
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 87,12 % |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/03/22 |
Director of Finance/CFO | - | 07/03/22 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/03/22 |
Rupalee Mehta
BRD | Director/Board Member | - | 07/03/22 |
Lucas Leone
BRD | Director/Board Member | - | 07/03/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+30,88 % | 699 Md | |
+25,07 % | 571 Md | |
-4,61 % | 364 Md | |
+18,18 % | 326 Md | |
+3,07 % | 286 Md | |
+14,68 % | 236 Md | |
+4,71 % | 198 Md | |
-12,43 % | 194 Md | |
-4,52 % | 154 Md |